Alliance members participating in the survey for 2020 progress report
AMR INDUSTRY ALLIANCE MEMBERS
As of September 2019, the organizations listed below were members of the AMR Industry Alliance. Those marked with an asterisk (*) responded to part or all of the second AMR Industry Alliance survey on progress, conducted in 2019. Those marked with an obelisk (†) responded to part or all of the first AMR Industry Alliance survey on progress, conducted in 2017.
Biotechnology companies/SMEs
Allecra Therapeutics, Germany
*†Aequor Inc., United States
*Agile Sciences, United States
*AiCuris Anti-infective Cures GmbH, Germany
*†Alaxia Pharma, France
*Amplyx, United States
*Antabio, France
*Antibiotic Adjuvant, United States
*BioVersys AG, Switzerland
*Bugworks Research, India
Cardeas Pharma, United States
*Combioxin, Switzerland
*Curza, United States
*†Da Volterra, France
Deinove, France
Destiny Pharma Ltd., United Kingdom
Eligo Bioscience, France
*†Entasis Therapeutics, United States
*Fedora Pharmaceuticals Inc., Canada
Fastinov, Portugal
*Forge Therapeutics, United States
*Meiji Seika Pharma Co., Japan
Helperby Therapeutics plc, United Kingdom
†iNtRON Biotechnology Inc., Korea
MaaT Pharma, France
Macrolide Pharmaceuticals Inc., United States
*Melinta Therapeutics Inc., United States
Microbion Corporation, United States
MicuRx Pharmaceuticals Inc., China and United States
*Moderna, United States
*Motif Bio, France
Mutabilis, France
†Nabriva Therapeutics AG, Austria
NAICONS, Italy
Northern Antibiotics Ltd., Finland
*†Nosopharm, France
*NovaBiotics, United Kingdom
†NovaDigm Therapeutics Inc., United States
OJBio Ltd., United Kingdom
*Paratek, United States
*†Peptilogics Inc., United States
Pherecydes Pharma, France
*Rebiotix, United States
*Scynexis, United States
*SetLance, Italy
*SinSa Labs, Sweden
*Soligenix, United States
*Spero Therapeutics LLC, United States
*Stochos Therapeutics, United States
*Summit Therapeutics, United Kingdom
Synthetic Genomics, United States
Sysmex, United Kingdom
TAXISpharma, United States
*†Tetraphase Pharmaceuticals, United States
*Venatorx Pharmaceuticals Inc., United States
VibioSphen, France
Vitas Pharma Ltd., India
*Xellia, Denmark
Large research-based biopharmaceutical companies
*†AstraZeneca plc, United Kingdom
*Boehringer Ingelheim, Germany
*Evotec, Germany
*†F. Hoffmann-La Roche AG.
*†GlaxoSmithKline plc, United Kingdom
*†Johnson & Johnson, United States
*†Merck KGaA, Germany
*†MSD (known as Merck and Co., Inc. in the U.S. and Canada), United States
*†Otsuka, Japan
*†Pfizer Inc., United States
*†Sanofi S.A., France
*†Shionogi & Co. Ltd., Japan
*Sumitomo Dainippon Pharma, Japan
Generics
*Aurobindo, India
*†Centrient Pharmaceuticals, The Netherlands
*Cipla Ltd., India
*†Mylan, United Kingdom
*NGB Laboratories, India
*†Novartis AG1, Switzerland
*†Teva Pharmaceuticals, Ltd. Israel
Diagnostics
*†BD, United States
*†bioM̩érieux SA, France
Cepheid, United States
*†Curetis AG, Germany
*HemoCue AB, Sweden
*Luminex B.V., The Netherlands
*MeMed, Israel
*Mobidiag Oy Ltd., Finland
*Momentum Bioscience Ltd., United Kingdom
*Nemis Technologies, Germany
*Qiagen, Germany
QuantuMDx Ltd., United Kingdom
Spectromics, United Kingdom
Industry Associations2
AdvaMedDx
Alliance of Biotech companies in Europe combating Anti-Microbial resistance (BEAM Alliance)
Antimicrobial Innovation Alliance (AIA)
Association Innovative Medicines, The Netherlands
Association of the British Pharmaceutical Industry (ABPI)
Biotechnology Innovation Organization (BIO)
British Generic Manufacturers Association (BGMA)
British In Vitro Diagnostics Association (BIVDA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
German Association of Research-Based Pharmaceutical Companies (VFA)
International Federation of Pharmaceutical Manufacturers & Association (IFPMA
Japan Pharmaceutical Manufacturers Association (JPMA)
Medicines for Europe
UK BioIndustry Association (BIA)
1 For the purposes of this report, and due to the predominant nature of its AMR-relevant business, where a sector breakdown is provided, data submitted by Novartis were included under the generics sector, rather than the large research-based biopharmaceutical sector.
2 Industry associations were not asked to participate in the survey, as it focuses specifically on company activity.